Reaction

Cystitis Viral reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 376 reports · 42 co-occurring drugs

As of the last recalculation, Cystitis Viral appears in 376 FAERS reports alongside 42 co-occurring drug terms. The strongest observed disproportionality signal is BUSULFAN (PRR 459.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Busulfan	97	459.6	462.4
Fludarabine Phosphate	159	387.1	388.7
Mesna Injection	23	164.1	164.5
Mesna	23	161.0	161.5
Thiotepa	25	155.2	155.6
Micafungin Sodium	22	152.5	152.9
Polatuzumab Vedotin	23	138.9	139.2
Cyclophosphamide Injection, Solution	177	103.7	103.8
Cyclophosphamide	177	103.7	103.8
Cyclophosphamide For Injection	177	103.7	103.8
Melphalan	37	99.8	99.9
Posaconazole Delayed-Release	18	95.2	95.4
Melphalan Hydrochloride	38	93.2	93.4
Sirolimus	21	91.3	91.5
Mycophenolate Mofetil	138	88.3	88.4
Mycophenolate Mofetil Hydrochloride	138	88.1	88.2
Cyclosporine	116	83.0	83.1
Voriconazole Injection	29	80.0	80.1
Anti-Thymocyte Globulin (Rabbit)	11	77.7	77.8
Alemtuzumab	25	76.6	76.7
Tacrolimus Ointment 0.1%	117	75.1	75.1
Tacrolimus Extended-Release Capsules	117	74.8	74.9
Mycophenilic Acid	26	74.5	74.6
Tacrolimus	129	68.9	68.9
Voriconazole	34	68.0	68.1
Bendamustine Hcl	18	67.4	67.5
Posaconazole	18	64.4	64.4
Valganciclovir Hydrochloride Powder,	13	61.1	61.1
Filgrastim	36	58.5	58.5
Mycophenolic Acid	26	48.2	48.3
Ganciclovir	8	44.2	44.2
Tofacitinib Citrate	10	43.3	43.4
Ganciclovir Sodium	8	42.7	42.8
Valganciclovir	14	42.7	42.7
Valganciclovir Hydrochloride	14	42.7	42.7
Cytarabine	38	38.8	38.9
Canakinumab	7	36.5	36.5
Eltrombopag Olamine	11	27.2	27.2
Etoposide	33	27.1	27.2
Bendamustine Hydrochloride	5	23.4	23.4
Blinatumomab	4	21.4	21.4
Axicabtagene Ciloleucel	3	17.0	17.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.